The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
A similar split set up to today
The Eagles of Death Metal want to be the first to play the Bataclan when it reopens, the lead singer has said in an emotional interview.
Cheap commercial spaceflight took one giant leap closer to reality after Blue Origin successfully landed a rocket - upright - in Texas.